Drug Research
FDA Workshop On AI In Drug Development: The Key Takeaways
A full-day training called Artificial Intelligence in Drug and Biological Product Development was held on August 6, 2024, by the Food and Drug Administration...
Drug Research
Future of Cell And Gene Therapy: Overcoming Growth Hurdles
It is not always easy to go from novel research to a working business plan. There are still problems with prices and safety, as...
Drug Research
Rising Cell & Gene Therapy Market: Trends And Technology
In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the market is projected to...
Drug Research
The Inroads and Issues In Gene Therapy Manufacturing Realm
Cell and gene treatments are now one of the pharmaceutical industry's fastest-growing segments, with more and more being investigated for a variety of purposes.
The...
Drug Research
Global Pharmaceutical Water Market To Reach $96.97B By 2033
The pharmaceutical water market is expected to grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2034. It was valued...
Clinical Trials
Biotechs Recursion, Exscientia Merge For $850M And 10 Trials
The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months,...
Press Releases
Abzena Supplies Clinical Trial Material for Angiex’s Phase I Study of AGX101, a First-in-Class TM4SF1-directed ADC
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for their Phase 1 clinical trial...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read